Foghorn Therapeutics (FHTX)
(Real Time Quote from BATS)
$5.99 USD
+0.43 (7.73%)
Updated May 13, 2024 02:27 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/2/24 |
---|---|
Current Quarter | -0.60 |
EPS Last Quarter | -0.59 |
Last EPS Surprise | -7.27% |
ABR | 1.33 |
Earnings ESP
|
1.67% |
---|---|
Current Year | -2.20 |
Next Year | -1.67 |
EPS (TTM) | -2.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.60M | 6.74M | 25.24M | 38.10M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 7.90M | 7.90M | 28.70M | 54.00M |
Low Estimate | 5.30M | 5.57M | 21.77M | 22.20M |
Year ago Sales | 5.60M | 17.48M | 34.15M | 25.24M |
Year over Year Growth Est. | 17.86% | -61.47% | -26.12% | 50.98% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.60 | -0.56 | -2.20 | -1.67 |
# of Estimates | 3 | 2 | 3 | 4 |
Most Recent Consensus | -0.52 | -0.66 | -2.56 | -2.36 |
High Estimate | -0.52 | -0.45 | -1.97 | -1.36 |
Low Estimate | -0.66 | -0.66 | -2.56 | -2.36 |
Year ago EPS | -0.70 | -0.34 | -2.34 | -2.20 |
Year over Year Growth Est. | 14.29% | -64.71% | 5.98% | 24.17% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 0 | 1 |
Up Last 30 Days | 1 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 2 | 3 | 2 |
Down Last 30 Days | 0 | 2 | 3 | 2 |
Down Last 60 Days | 0 | 2 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.60 | -0.56 | -2.20 | -1.67 |
7 Days Ago | -0.58 | -0.53 | -2.05 | -1.61 |
30 Days Ago | -0.58 | -0.53 | -2.05 | -1.61 |
60 Days Ago | -0.58 | -0.53 | -2.05 | -1.61 |
90 Days Ago | -0.70 | -0.63 | -2.40 | -1.98 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.59 | -0.56 | -2.20 | -1.74 |
Zacks Consensus Estimate | -0.60 | -0.56 | -2.20 | -1.67 |
Earnings ESP | 1.67% | 0.00% | 0.00% | -4.51% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.59 | -0.57 | -0.34 | -0.70 | NA |
Estimate | -0.55 | -0.79 | -0.72 | -0.73 | NA |
Difference | -0.04 | 0.22 | 0.38 | 0.03 | 0.15 |
Surprise | -7.27% | 27.85% | 52.78% | 4.11% | 19.37% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more